Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
302.00    -1.00 (-0.33%)
Bid:
305.00
Ask:
308.00
Spread: 3.00 (0.984%)
Market Cap: £271.46m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Directorate Change

10 Jun 2021 07:01

RNS Number : 3975B
Norcros PLC
10 June 2021
 

 

Norcros plc

("Norcros" or "the Company")

Directorate Change

Norcros plc, a market leading supplier of high quality and innovative bathroom and kitchen products today announces that Shaun Smith, Chief Financial Officer, has notified the Board of his intention to retire as a director of the Company to pursue a non-executive director career, which the Board has accepted with effect from 31 July 2021. Mr Smith will remain an employee of the Company during the handover period to his successor and his retirement from the Company will take effect on 31 December 2021.

Norcros has concluded a thorough recruitment process with the decision to appoint James Eyre as successor. James has been the Group's Director of Corporate Development and Strategy, leading acquisitions at Norcros since 2014 and will assume the role of Chief Financial Officer effective 1 August 2021. James is a Chartered Accountant and has held senior finance roles at AstraZeneca, Bank of Ireland and N M Rothschild prior to joining Norcros.

Commenting on these changes, Nick Kelsall, Chief Executive Officer, said:

"We have accepted Shaun's decision to retire with considerable regret and I would like to put on record the Board's appreciation of his valued contribution as CFO of Norcros since 2016. We are delighted to promote James Eyre as our new CFO who I know will provide both strong continuity and financial stewardship given his experience and deep knowledge of our Group. I wish James every success in his new role and Shaun best wishes for the future."

Note: There are no disclosures concerning James Eyre to be made under Listing Rule 9.6.13.

Further enquiries:

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Chief Executive Officer

Shaun Smith, Chief Financial Officer

 

 

 

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAXKNEFLFEFA
Date   Source Headline
24th Jul 20247:00 amRNSAGM Trading Statement
22nd Jul 20244:06 pmRNSDirector Dealings - APSP Share Option exercises
19th Jul 202410:36 amRNSTotal Voting Rights
2nd Jul 20241:51 pmRNSHolding(s) in Company
1st Jul 202412:53 pmRNSTotal Voting Rights
1st Jul 20247:00 amRNSDirector Declaration
21st Jun 20247:00 amRNSAnnual Financial Report and Notice of 2024 AGM
18th Jun 20243:50 pmRNSDirector/PDMR Shareholding
13th Jun 20247:00 amRNSResults for the year ended 31 March 2024
31st May 20247:00 amRNSTotal Voting Rights
30th May 20244:15 pmRNSHolding(s) in Company
24th May 20247:00 amRNSAppointment of Independent Non-Executive Director
23rd May 20247:30 amRNSDirector Declaration
20th May 20247:00 amRNSSale of Johnson Tiles UK
7th May 20247:00 amRNSNorcros business wins King's Award for Enterprise
1st May 202410:52 amRNSVoting Rights and Share Capital Update
1st May 20247:00 amRNSCapital Markets Event
25th Apr 20247:00 amRNSSale of Johnson Tiles UK
22nd Apr 20242:00 pmRNSInvestor Webinar 7 May 2024
12th Apr 20243:40 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSTrading update
28th Mar 20247:00 amRNSBlock listing Six Monthly Return
28th Mar 20247:00 amRNSVoting Rights and Share Capital Update
1st Mar 20242:09 pmRNSDirectors Share Dealing
23rd Jan 202411:40 amRNSHolding(s) in Company
23rd Jan 20247:00 amRNSAppointment of Joint Corporate Broker
22nd Dec 20237:00 amRNSEmployee SAYE awards and director share dealing
1st Dec 20234:35 pmRNSDirector Declaration
23rd Nov 20234:06 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
3rd Nov 20239:00 amRNSInvestor Presentation
12th Oct 20237:00 amRNSTrading Update
1st Sep 20237:00 amRNSBlock Listing Six Monthly Return
11th Aug 20234:36 pmRNSDirector's Dealings
26th Jul 20234:50 pmRNSResults of AGM
26th Jul 20231:06 pmRNSDirector's Dealings
26th Jul 20237:00 amRNSAGM Trading Statement
10th Jul 20235:59 pmRNSDirector's Dealings
23rd Jun 20237:00 amRNSAnnual Financial Report and Notice of 2023 AGM
15th Jun 20237:00 amRNSFinal Results
30th May 20237:00 amRNSDirectorate Changes
13th Apr 20237:00 amRNSTrading Update
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20234:16 pmRNSHolding(s) in Company
21st Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20233:19 pmRNSBlock Listing Six Monthly Return
14th Feb 20237:00 amRNSDirectorate Update
30th Jan 20237:00 amRNSCEO Succession
24th Jan 20237:00 amRNSDirectorate Update
15th Dec 20229:40 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.